
- 392 pages
- English
- PDF
- Available on iOS & Android
About this book
The Business of Biotechnology: From the Bench to the Street thoroughly examines the existing and future business challenges for biotechnology, providing a unique insight into the intricate web of critical factors with which biotechnology entrepreneurs must come to terms if they wish to be successful. The book begins with discussions of the evolution of biotechnology; entrepreneurship in the biotechnology industry; university-industry technology transfer process; and the life cycle of a biotechnology company. It considers the prospects for biotechnology, from the perspective of a venture capitalist and human resource practitioner. There are separate chapters that deal with the cloning and expression of recombinant gene products; developing strategies to reduce the cost-to-produce (CTP) therapeutic proteins; intellectual property protection; and the regulation of commercial biotechnology. The final chapters cover the marketing of biotechnology companies and products; the performance of biotechnology stocks; mergers and acquisitions in the biotechnology industry, and prospects for the Japanese and European biotechnology industry.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Front Cover
- The Business of Biotechnology: From the Bench to the Street
- Copyright Page
- Table of Contents
- CONTRIBUTING AUTHORS
- FOREWORD
- PREFACE
- CHAPTER 1. MIRACLES AND MONEY: THE EVOLUTION OF A NEW INDUSTRY
- CHAPTER 2. CAPITALIZING ON NEW OPPORTUNITIES: ENTREPRENEURSHIP IN BIOTECHNOLOGY
- CHAPTER 3. THE LIFEBLOOD OF BIOTECHNOLOGY: UNIVERSITYâINDUSTRY TECHNOLOGY TRANSFER
- CHAPTER 4. THE SEARCH FOR DOLLARS: LIFE CYCLE OF A BIOTECHNOLOGY COMPANY
- CHAPTER 5. FUELING DREAMS INTO REALITIES: A VENTURE CAPITALIST'S PERSPECTIVE
- CHAPTER 6. GROWING THE ORGANIZATION: PEOPLE-POWER FROM RESEARCH AND DEVELOPMENT START-UP TO MARKET-DRIVEN ENTERPRISE
- CHAPTER 7. HOPE IN THE VIAL: THE CLONING AND EXPRESSION OF RECOMBINANT PRODUCTS
- CHAPTER 8. SCIENCE, TECHNOLOGY, AND POLITICS: REAL FACTORS IN SELECTING A MAMMALIAN CELL BIOREACTOR
- CHAPTER 9. THE PROTECTION OF INTELLECTUAL PROPERTY IN BIOTECHNOLOGY
- CHAPTER 10. IMPACT OF GOVERNMENT REGULATION ON COMMERCIAL BIOTECHNOLOGY
- CHAPTER 11. BIOTECHNOLOGY AND THE U.S. GOVERNMENT: THE POT AT THE END OF THE RAINBOW?
- CHAPTER 12. OURS, THEIRS OR BOTH? STRATEGIC PLANNING AND DEAL MAKING
- CHAPTER 13. IN THE TRENCHES: THE MARKETING AND SELLING OF BIOTECHNOLOGY
- CHAPTER 14. CREATING AND MARKETING THE IMAGE OF THE BIOTECHNOLOGY COMPANY
- CHAPTER 15. WALL STREET AND BIOTECHNOLOGY: A WALK ON THE WILDER SIDE
- CHAPTER 16. MERGERS AND ACQUISITIONS WITHIN THE BIOTECHNOLOGY INDUSTRY
- CHAPTER 17. JAPAN'S DILEMMA: WHERE AND WHEN?
- CHAPTER 18. EUROPHORIA: BIOPHARMACEUTICALS IN THE EMERGING EUROPEAN MARKET
- CHAPTER 19. BIOTECHNOLOGY MEGATRENDS: LESSONS FROM THE PASTâVISIONS OF THE FUTURE
- INDEX